Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders

Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders

US Patent 8791267 · Granted Jul 29, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhanc2025
Substituted [1,2,4]triazolo[4,3-c]pyrimidines that induce degradation of embryon2025
Methods of treating neurodegenerative disease with substituted n-hexanoic-l-tyro2025
Bifunctional compounds comprising Apcin-A and their use in the treatment of canc2025
Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of in2025
Hydrazide containing nuclear transport modulators and uses thereof2025
Heteroaryl inhibitors of PDE42025
Heteroaryl inhibitors of PDE42025
Substituted fused pyrrolo-diazepinones and uses thereof2025
Substituted heterocycles as c-MYC targeting agents2024
Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhanc2024
Substituted [1,2,4]triazolo[4,3-c]pyrimidin-5-amines and proteolysis-targeting c2024